Agonist-induced lipoxin A4 generation in vitro and in aspirin-sensitive asthmatics: detection by a novel lipoxin A4-ELISA.
Levy
B D
BD
Department of Medicine, Brigham & Women's Hospital, Boston, MA 02115, USA.
Drazen
J M
JM
Serhan
C N
CN
D001241:Aspirin / Q000494:pharmacology*; D001249:Asthma / Q000097:blood*; D001792:Blood Platelets / Q000187:drug effects / Q000502:physiology*; D018592:Cross-Over Studies; D004311:Double-Blind Method; D004797:Enzyme-Linked Immunosorbent Assay; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000494:pharmacology*; D006801:Humans; D006893:Hydroxyeicosatetraenoic Acids / Q000096:biosynthesis* / Q000097:blood; D044045:Lipoxins; D009504:Neutrophils / Q000187:drug effects / Q000502:physiology*; D011897:Random Allocation; D011994:Recombinant Proteins / Q000494:pharmacology
D006893:Hydroxyeicosatetraenoic Acids; D044045:Lipoxins; D011994:Recombinant Proteins; C040527:lipoxin A4; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D001241:Aspirin